In hepatic carcinoma, suppression of DRP1-dependent mitophagy using mitochondrial division inhibitor 1 (mdivi-1) or the lysosomal inhibitor, bafilomycin, increases cellular susceptibility to chemotherapeutic agents [189]. This evidence concerns the gene DNM1L and hepatocellular carcinoma.